Beijing Health (Holdings) Limited
Beijing Health (Holdings) Limited (2389.HK) Stock Competitors & Peer Comparison
See (2389.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2389.HK | HK$0.06 | -1.56% | 387.8M | -6.40 | -HK$0.01 | N/A |
| 6618.HK | HK$48.64 | +1.63% | 150.7B | 24.77 | HK$1.90 | N/A |
| 1989.HK | HK$102.80 | +2.29% | 84.8B | -2345.00 | -HK$0.04 | N/A |
| 6078.HK | HK$12.19 | +6.56% | 7.1B | 36.81 | HK$0.31 | N/A |
| 1951.HK | HK$2.49 | +6.41% | 6.4B | -5.80 | -HK$0.41 | N/A |
| 2273.HK | HK$26.98 | -1.68% | 6.2B | 17.06 | HK$1.60 | +2.78% |
| 2609.HK | HK$4.56 | +25.62% | 5.4B | -135.33 | -HK$0.03 | N/A |
| 2373.HK | HK$19.95 | +3.37% | 5.1B | 13.01 | HK$1.55 | +2.58% |
| 1515.HK | HK$2.75 | +2.61% | 3.4B | 6.14 | HK$0.44 | +5.33% |
| 2508.HK | HK$4.61 | +0.22% | 2.9B | 9.41 | HK$0.49 | N/A |
Stock Comparison
2389.HK vs 6618.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 6618.HK has a market cap of 150.7B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 6618.HK trades at HK$48.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 6618.HK's P/E ratio is 24.77. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 6618.HK's ROE of +0.09%. Regarding short-term risk, 2389.HK is more volatile compared to 6618.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 6618.HK's competition here
2389.HK vs 1989.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 1989.HK has a market cap of 84.8B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 1989.HK trades at HK$102.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 1989.HK's P/E ratio is -2345.00. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 1989.HK's ROE of -0.16%. Regarding short-term risk, 2389.HK is less volatile compared to 1989.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 1989.HK's competition here
2389.HK vs 6078.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 6078.HK has a market cap of 7.1B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 6078.HK trades at HK$12.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 6078.HK's P/E ratio is 36.81. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 6078.HK's ROE of +0.05%. Regarding short-term risk, 2389.HK is less volatile compared to 6078.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 6078.HK's competition here
2389.HK vs 1951.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 1951.HK has a market cap of 6.4B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 1951.HK trades at HK$2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 1951.HK's P/E ratio is -5.80. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 1951.HK's ROE of -0.11%. Regarding short-term risk, 2389.HK is more volatile compared to 1951.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 1951.HK's competition here
2389.HK vs 2273.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2273.HK has a market cap of 6.2B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2273.HK trades at HK$26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2273.HK's P/E ratio is 17.06. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2273.HK's ROE of +0.15%. Regarding short-term risk, 2389.HK is less volatile compared to 2273.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 2273.HK's competition here
2389.HK vs 2609.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2609.HK has a market cap of 5.4B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2609.HK trades at HK$4.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2609.HK's P/E ratio is -135.33. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2609.HK's ROE of N/A. Regarding short-term risk, 2389.HK is less volatile compared to 2609.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 2609.HK's competition here
2389.HK vs 2373.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2373.HK has a market cap of 5.1B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2373.HK trades at HK$19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2373.HK's P/E ratio is 13.01. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2373.HK's ROE of +0.29%. Regarding short-term risk, 2389.HK is less volatile compared to 2373.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 2373.HK's competition here
2389.HK vs 1515.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 1515.HK has a market cap of 3.4B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 1515.HK trades at HK$2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 1515.HK's P/E ratio is 6.14. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 1515.HK's ROE of +0.08%. Regarding short-term risk, 2389.HK is more volatile compared to 1515.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 1515.HK's competition here
2389.HK vs 2508.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2508.HK has a market cap of 2.9B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2508.HK trades at HK$4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2508.HK's P/E ratio is 9.41. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2508.HK's ROE of N/A. Regarding short-term risk, 2389.HK is more volatile compared to 2508.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 2508.HK's competition here
2389.HK vs 2522.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2522.HK has a market cap of 2.1B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2522.HK trades at HK$5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2522.HK's P/E ratio is -52.82. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2522.HK's ROE of -0.02%. Regarding short-term risk, 2389.HK is less volatile compared to 2522.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 2522.HK's competition here
2389.HK vs 0708.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 0708.HK has a market cap of 1.8B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 0708.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 0708.HK's P/E ratio is -0.06. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 0708.HK's ROE of +0.21%. Regarding short-term risk, 2389.HK is less volatile compared to 0708.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 0708.HK's competition here
2389.HK vs 2219.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2219.HK has a market cap of 1.8B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2219.HK trades at HK$2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2219.HK's P/E ratio is 9.56. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2219.HK's ROE of +0.07%. Regarding short-term risk, 2389.HK is more volatile compared to 2219.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 2219.HK's competition here
2389.HK vs 3886.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 3886.HK has a market cap of 1.8B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 3886.HK trades at HK$0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 3886.HK's P/E ratio is -13.00. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 3886.HK's ROE of +0.00%. Regarding short-term risk, 2389.HK is less volatile compared to 3886.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 3886.HK's competition here
2389.HK vs 3309.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 3309.HK has a market cap of 1.5B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 3309.HK trades at HK$1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 3309.HK's P/E ratio is 16.13. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 3309.HK's ROE of +0.06%. Regarding short-term risk, 2389.HK is more volatile compared to 3309.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 3309.HK's competition here
2389.HK vs 1526.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 1526.HK has a market cap of 1.4B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 1526.HK trades at HK$0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 1526.HK's P/E ratio is 4.09. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 1526.HK's ROE of +0.18%. Regarding short-term risk, 2389.HK is more volatile compared to 1526.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 1526.HK's competition here
2389.HK vs 9960.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 9960.HK has a market cap of 1.2B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 9960.HK trades at HK$1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 9960.HK's P/E ratio is -9.67. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 9960.HK's ROE of -0.04%. Regarding short-term risk, 2389.HK is more volatile compared to 9960.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 9960.HK's competition here
2389.HK vs 0383.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 0383.HK has a market cap of 1.1B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 0383.HK trades at HK$1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 0383.HK's P/E ratio is -52.00. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 0383.HK's ROE of -0.01%. Regarding short-term risk, 2389.HK is more volatile compared to 0383.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 0383.HK's competition here
2389.HK vs 6639.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 6639.HK has a market cap of 1B. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 6639.HK trades at HK$1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 6639.HK's P/E ratio is 30.50. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 6639.HK's ROE of +0.01%. Regarding short-term risk, 2389.HK is less volatile compared to 6639.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 6639.HK's competition here
2389.HK vs 2453.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2453.HK has a market cap of 963.9M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2453.HK trades at HK$1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2453.HK's P/E ratio is -1.78. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2453.HK's ROE of -0.15%. Regarding short-term risk, 2389.HK is less volatile compared to 2453.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 2453.HK's competition here
2389.HK vs 9906.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 9906.HK has a market cap of 936M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 9906.HK trades at HK$1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 9906.HK's P/E ratio is 78.00. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 9906.HK's ROE of +0.02%. Regarding short-term risk, 2389.HK is more volatile compared to 9906.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 9906.HK's competition here
2389.HK vs 1846.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 1846.HK has a market cap of 865.9M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 1846.HK trades at HK$2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 1846.HK's P/E ratio is 11.74. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 1846.HK's ROE of +0.06%. Regarding short-term risk, 2389.HK is less volatile compared to 1846.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 1846.HK's competition here
2389.HK vs 3689.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 3689.HK has a market cap of 675.5M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 3689.HK trades at HK$2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 3689.HK's P/E ratio is 7.77. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 3689.HK's ROE of +0.05%. Regarding short-term risk, 2389.HK is more volatile compared to 3689.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 3689.HK's competition here
2389.HK vs 2120.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2120.HK has a market cap of 599.1M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2120.HK trades at HK$8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2120.HK's P/E ratio is 9.90. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2120.HK's ROE of +0.04%. Regarding short-term risk, 2389.HK is more volatile compared to 2120.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 2120.HK's competition here
2389.HK vs 3869.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 3869.HK has a market cap of 543.3M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 3869.HK trades at HK$3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 3869.HK's P/E ratio is 33.17. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 3869.HK's ROE of +0.32%. Regarding short-term risk, 2389.HK is more volatile compared to 3869.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 3869.HK's competition here
2389.HK vs 2189.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2189.HK has a market cap of 460M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2189.HK trades at HK$0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2189.HK's P/E ratio is 23.00. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2189.HK's ROE of +0.05%. Regarding short-term risk, 2389.HK is less volatile compared to 2189.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 2189.HK's competition here
2389.HK vs 0722.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 0722.HK has a market cap of 373M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 0722.HK trades at HK$0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 0722.HK's P/E ratio is 11.50. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 0722.HK's ROE of +0.04%. Regarding short-term risk, 2389.HK is more volatile compared to 0722.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 0722.HK's competition here
2389.HK vs 1419.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 1419.HK has a market cap of 303.6M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 1419.HK trades at HK$0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 1419.HK's P/E ratio is 11.43. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 1419.HK's ROE of +0.04%. Regarding short-term risk, 2389.HK is more volatile compared to 1419.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 1419.HK's competition here
2389.HK vs 1518.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 1518.HK has a market cap of 287.9M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 1518.HK trades at HK$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 1518.HK's P/E ratio is -5.90. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 1518.HK's ROE of -0.08%. Regarding short-term risk, 2389.HK is less volatile compared to 1518.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 1518.HK's competition here
2389.HK vs 8405.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 8405.HK has a market cap of 276M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 8405.HK trades at HK$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 8405.HK's P/E ratio is 9.86. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 8405.HK's ROE of +0.12%. Regarding short-term risk, 2389.HK is more volatile compared to 8405.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 8405.HK's competition here
2389.HK vs 0286.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 0286.HK has a market cap of 251.8M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 0286.HK trades at HK$1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 0286.HK's P/E ratio is -0.86. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 0286.HK's ROE of -0.22%. Regarding short-term risk, 2389.HK is more volatile compared to 0286.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 0286.HK's competition here
2389.HK vs 2293.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2293.HK has a market cap of 170.2M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2293.HK trades at HK$0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2293.HK's P/E ratio is 10.63. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2293.HK's ROE of +0.07%. Regarding short-term risk, 2389.HK is more volatile compared to 2293.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 2293.HK's competition here
2389.HK vs 8143.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 8143.HK has a market cap of 122.9M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 8143.HK trades at HK$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 8143.HK's P/E ratio is -3.63. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 8143.HK's ROE of -5.74%. Regarding short-term risk, 2389.HK is more volatile compared to 8143.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 8143.HK's competition here
2389.HK vs 2135.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 2135.HK has a market cap of 82.4M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 2135.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 2135.HK's P/E ratio is -1.06. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 2135.HK's ROE of -0.64%. Regarding short-term risk, 2389.HK is less volatile compared to 2135.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 2135.HK's competition here
2389.HK vs 8357.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 8357.HK has a market cap of 78M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 8357.HK trades at HK$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 8357.HK's P/E ratio is -12.50. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 8357.HK's ROE of -0.27%. Regarding short-term risk, 2389.HK is less volatile compared to 8357.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 8357.HK's competition here
2389.HK vs 8307.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 8307.HK has a market cap of 59.5M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 8307.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 8307.HK's P/E ratio is -15.00. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 8307.HK's ROE of -0.56%. Regarding short-term risk, 2389.HK is more volatile compared to 8307.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 8307.HK's competition here
2389.HK vs 8161.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 8161.HK has a market cap of 22.5M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 8161.HK trades at HK$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 8161.HK's P/E ratio is 2.45. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 8161.HK's ROE of +1.39%. Regarding short-term risk, 2389.HK is less volatile compared to 8161.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2389.HK.Check 8161.HK's competition here
2389.HK vs 8437.HK Comparison April 2026
2389.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2389.HK stands at 387.8M. In comparison, 8437.HK has a market cap of 16.7M. Regarding current trading prices, 2389.HK is priced at HK$0.06, while 8437.HK trades at HK$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2389.HK currently has a P/E ratio of -6.40, whereas 8437.HK's P/E ratio is -0.53. In terms of profitability, 2389.HK's ROE is -0.05%, compared to 8437.HK's ROE of +0.26%. Regarding short-term risk, 2389.HK is more volatile compared to 8437.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2389.HK.Check 8437.HK's competition here